SEC Tracker
Get the app
Person · CIK 1852129

Andrew Callos

EVP at Cytokinetics

Source: Forms 3, 4, 5 and 144 on SEC EDGAR

Sold on Form 4$19M
Noticed on Form 144$17.8M
Bought on Form 4$0
Companies1

Holdings now

As reported after the latest Form 3, 4 or 5 at each company.

How these figures work

Options and RSUs are from the latest filing that lists them; earlier grants may also be held. Holdings can be out of date when a person stops filing.

CompanySecurityHeldShares or unitsAs of
Cytokinetics CYTKCommon StockDirectly58,555Aug 31, 2026 · Filing · EDGAR

Sold and noticed by quarter

Andrew Callos: dollars sold on Form 4 and noticed on Form 144 per quarter, Q1 2025 to Q4 2026$5.3M$0Q1 2025: $2.1M noticed on Form 144Q1 2025: $2.4M sold on Form 4Q2 2025: $581K noticed on Form 144Q2 2025: $527K sold on Form 4Q3 2025: $0 noticed on Form 144Q3 2025: $0 sold on Form 4Q4 2025: $3.7M noticed on Form 144Q4 2025: $3.6M sold on Form 4Q1 2026: $4.2M noticed on Form 144Q1 2026: $4.8M sold on Form 4Q2 2026: $5.3M noticed on Form 144Q2 2026: $4.5M sold on Form 4Q3 2026: $1.9M noticed on Form 144Q3 2026: $3.1M sold on Form 4Q4 2026: $0 noticed on Form 144Q4 2026: $0 sold on Form 4Q1 2025Q3 2025Q1 2026Q3 2026

Sold (Form 4) Noticed (Form 144) Bought (Form 4)

Quarterly totals as a table
QuarterSold (Form 4)Noticed (Form 144)
Q3 2026$3.1M$1.9M
Q2 2026$4.5M$5.3M
Q1 2026$4.8M$4.2M
Q4 2025$3.6M$3.7M
Q2 2025$527K$581K
Q1 2025$2.4M$2.1M

Planned sales (Form 144) and the sales that followed

Each Form 144 notice of a planned sale, grouped by broker and 10b5-1 plan, with the Form 4 sales we matched to it.

How we match

A Form 144 is a notice of a planned sale by an affiliate. SEC Tracker matches each notice to Form 4 sales by the same person at the same company within 90 days of the notice, up to the shares noticed. The match is our inference, not something either filing states.

Notice dateNoticedPlanned saleOutcomeLinks
Cytokinetics CYTK · Morgan Stanley Smith Barney · 10b5-1 plan adopted Sep 5, 2025 · 8 notices
Jul 30, 202624,000 · ~$1.9MJul 30, 2026Sold as noticed Sold 24,000 in 2 sales, Jul 30 to Aug 31 · $1.8M Form 4 (1) · Form 4 (2)Filing · EDGAR
Apr 15, 202679,639 · ~$5.3MApr 15, 2026Sold as noticed Sold 79,639 in 6 sales, Apr 15 to Jul 1 · $5.7M Form 4 (1) · Form 4 (2) · Form 4 (3) · Form 4 (4) · Form 4 (5) · Form 4 (6)Filing · EDGAR
Mar 31, 20263,639 · ~$229KMar 31, 2026Sold as noticed Sold 3,639 at $65.00 on Mar 31 · $237K Form 4Filing · EDGAR
Mar 18, 20261,930 · ~$120KMar 18, 2026Sold as noticed Sold 1,930 at $62.07 on Mar 18 · $120K Form 4Filing · EDGAR
Mar 16, 20261,709 · ~$103KMar 16, 2026Sold as noticed Sold 1,709 at $61.03 on Mar 16 · $104K Form 4Filing · EDGAR
Jan 2, 202659,570 · ~$3.8MJan 2, 2026Sold as noticed Sold 59,570 in 8 sales, Jan 2 to Mar 5 · $3.7M Form 4 (1) · Form 4 (2) · Form 4 (3) · Form 4 (4) · Form 4 (5) · Form 4 (6)Filing · EDGAR
Dec 29, 20251,809 · ~$114KDec 29, 2025Sold as noticed Sold 1,809 at $62.44 on Dec 29 · $113K Form 4Filing · EDGAR
Dec 5, 202553,528 · ~$3.6MDec 5, 2025Sold as noticed Sold 53,528 in 2 sales, Dec 5 to Dec 8 · $3.5M Form 4 (1) · Form 4 (2)Filing · EDGAR
Cytokinetics CYTK · Morgan Stanley Smith Barney · 10b5-1 plan adopted Dec 12, 2024 · 3 notices
Apr 7, 202515,547 · ~$581KApr 7, 2025Not sold within 90 daysFiling · EDGAR
Mar 14, 202521,000 · ~$932KMar 14, 2025Partly sold Sold 18,322 in 4 sales, Mar 17 to Jun 5 · $651K likely match Form 4 (1) · Form 4 (2) · Form 4 (3) · Form 4 (4)Filing · EDGAR
Mar 13, 202526,771 · ~$1.2MMar 13, 2025Partly sold Sold 24,341 in 3 sales, Mar 6 to Mar 17 · $1.1M likely match Form 4 (1) · Form 4 (2) · Form 4 (3)Filing · EDGAR
Sales without a matching Form 144 · 5 sales
No matching Form 144 found. Not every sale needs one: small sales and sales by people who are not affiliates are exempt.
———Sold without notice Cytokinetics (CYTK): Sold 2,916 at $62.15 on Mar 17, 2026 · $181KFiling · EDGAR
———Sold without notice Cytokinetics (CYTK): Sold 5,626 at $62.15 on Mar 17, 2026 · $350KFiling · EDGAR
———Sold without notice Cytokinetics (CYTK): Sold 2,582 at $60.72 on Mar 9, 2026 · $157KFiling · EDGAR
———Sold without notice Cytokinetics (CYTK): Sold 26,771 at $43.62 on Mar 13, 2025 · $1.2M (10b5-1 plan)Filing · EDGAR
———Sold without notice Cytokinetics (CYTK): Sold 1,114 at $42.88 on Mar 3, 2025 · $48KFiling · EDGAR

Every transaction, by company

Each Form 3, 4 and 5 transaction in plain words, newest first.

How these figures work

Values are shares times the price each filing states; grants, exercises and gifts usually state no price. Held after is what the filing reports was held once the transaction was done, directly or through the named holder.

Cytokinetics CYTK EVP, Chief Commercial Officer · filings 2021 to 2026 · sold $19M · $17.8M noticed on Form 144

DateTransactionSharesPriceValueHeld afterSource
Aug 31, 2026Option or RSU exercised or converted+10,000$23.26$233K68,555 directFiling · EDGAR
Aug 31, 2026Sale under a 10b5-1 plan−10,000$70.24$702K58,555 directFiling · EDGAR
Aug 31, 2026Option or RSU exercised or converted
Non-Qualified Stock Option (Right to Buy)
−10,0000 directFiling · EDGAR
Jul 30, 2026Option or RSU exercised or converted+14,000$23.26$326K72,555 directFiling · EDGAR
Jul 30, 2026Sale under a 10b5-1 plan−14,000$79.88$1.1M58,555 directFiling · EDGAR
Jul 30, 2026Option or RSU exercised or converted
Non-Qualified Stock Option (Right to Buy)
−14,00010,000 directFiling · EDGAR
Jul 1, 2026Option or RSU exercised or converted+15,000$23.26$349K73,555 directFiling · EDGAR
Jul 1, 2026Sale under a 10b5-1 plan−15,000$85.80$1.3M58,555 directFiling · EDGAR
Jul 1, 2026Option or RSU exercised or converted
Non-Qualified Stock Option (Right to Buy)
−15,00024,000 directFiling · EDGAR
Jun 1, 2026Option or RSU exercised or converted+15,000$23.26$349K73,555 directFiling · EDGAR
Jun 1, 2026Sale under a 10b5-1 plan−15,000$74.08$1.1M58,555 directFiling · EDGAR
Jun 1, 2026Option or RSU exercised or converted
Non-Qualified Stock Option (Right to Buy)
−15,00039,000 directFiling · EDGAR
May 5, 2026Option or RSU exercised or converted+11,333$39.13$443K69,888 directFiling · EDGAR
May 5, 2026Sale under a 10b5-1 plan−11,333$77.25$875K58,555 directFiling · EDGAR
May 5, 2026Option or RSU exercised or converted
Non-Qualified Stock Option (Right to Buy)
−11,33313,070 directFiling · EDGAR
May 1, 2026Option or RSU exercised or converted+15,857$37.63$597K74,412 directFiling · EDGAR
May 1, 2026Sale under a 10b5-1 plan−15,857$65.00$1M58,555 directFiling · EDGAR
May 1, 2026Option or RSU exercised or converted
Non-Qualified Stock Option (Right to Buy)
−15,8570 directFiling · EDGAR
Apr 30, 2026Option or RSU exercised or converted+15,000$23.26$349K73,555 directFiling · EDGAR
Apr 30, 2026Sale under a 10b5-1 plan−15,000$63.26$949K58,555 directFiling · EDGAR
Apr 30, 2026Option or RSU exercised or converted
Non-Qualified Stock Option (Right to Buy)
−15,00054,000 directFiling · EDGAR
Apr 15, 2026Sale under a 10b5-1 plan−7,449$66.02$492K58,555 directFiling · EDGAR
Mar 31, 2026Sale under a 10b5-1 plan−3,639$65.00$237K66,004 directFiling · EDGAR
Mar 18, 2026Sale under a 10b5-1 plan−1,930$62.07$120K78,185 directFiling · EDGAR
Mar 17, 2026Open-market or private sale−5,626$62.15$350K74,489 directFiling · EDGAR
Mar 17, 2026Open-market or private sale−2,916$62.15$181K71,573 directFiling · EDGAR
Mar 16, 2026Sale under a 10b5-1 plan−1,709$61.03$104K46,149 directFiling · EDGAR
Mar 15, 2026Grant or award from the company+20,64668,504 directFiling · EDGAR
Mar 15, 2026Grant or award from the company+13,32081,824 directFiling · EDGAR
Mar 15, 2026Grant or award from the company
Incentive Stock Option (Right to Buy)
+1,6651,665 directFiling · EDGAR
Mar 15, 2026Grant or award from the company
Non-Qualified Stock Option (Right to Buy)
+29,48029,480 directFiling · EDGAR
Mar 9, 2026Open-market or private sale−2,582$60.72$157K47,858 directFiling · EDGAR
Mar 5, 2026Option or RSU exercised or converted+11,000$39.13$430K76,440 directFiling · EDGAR
Mar 5, 2026Sale under a 10b5-1 plan−15,000$61.87$928K61,440 directFiling · EDGAR
Mar 5, 2026Sale under a 10b5-1 plan−11,000$61.88$681K50,440 directFiling · EDGAR
Mar 5, 2026Option or RSU exercised or converted+15,000$23.26$349K65,440 directFiling · EDGAR
Mar 5, 2026Option or RSU exercised or converted
Non-Qualified Stock Option (Right to Buy)
−11,00024,403 directFiling · EDGAR
Mar 5, 2026Option or RSU exercised or converted
Non-Qualified Stock Option (Right to Buy)
−15,00069,000 directFiling · EDGAR
Mar 2, 2026Option or RSU exercised or converted+886$37.63$33K51,326 directFiling · EDGAR
Mar 2, 2026Sale under a 10b5-1 plan−886$61.62$55K50,440 directFiling · EDGAR
Mar 2, 2026Option or RSU exercised or converted
Incentive Stock Option (Right to Buy)
−8860 directFiling · EDGAR
Feb 5, 2026Option or RSU exercised or converted+15,000$23.26$349K65,440 directFiling · EDGAR
Feb 5, 2026Sale under a 10b5-1 plan−15,000$61.93$929K50,440 directFiling · EDGAR
Feb 5, 2026Option or RSU exercised or converted
Non-Qualified Stock Option (Right to Buy)
−15,00084,000 directFiling · EDGAR
Feb 2, 2026Option or RSU exercised or converted+886$37.63$33K51,326 directFiling · EDGAR
Feb 2, 2026Sale under a 10b5-1 plan−886$62.10$55K50,440 directFiling · EDGAR
Feb 2, 2026Option or RSU exercised or converted
Incentive Stock Option (Right to Buy)
−886886 directFiling · EDGAR
Jan 5, 2026Option or RSU exercised or converted+15,000$23.26$349K65,440 directFiling · EDGAR
Jan 5, 2026Sale under a 10b5-1 plan−15,000$60.28$904K50,440 directFiling · EDGAR
Jan 5, 2026Option or RSU exercised or converted
Non-Qualified Stock Option (Right to Buy)
−15,00099,000 directFiling · EDGAR
Jan 2, 2026Sale under a 10b5-1 plan−913$62.09$57K50,440 directFiling · EDGAR
Jan 2, 2026Option or RSU exercised or converted+885$37.63$33K51,325 directFiling · EDGAR
Jan 2, 2026Sale under a 10b5-1 plan−885$63.16$56K50,440 directFiling · EDGAR
Jan 2, 2026Option or RSU exercised or converted
Incentive Stock Option (Right to Buy)
−8851,772 directFiling · EDGAR
Dec 29, 2025Sale under a 10b5-1 plan−1,809$62.44$113K51,353 directFiling · EDGAR
Dec 22, 2025Grant or award from the company+1,58952,249 directFiling · EDGAR
Dec 22, 2025Grant or award from the company+1,58853,837 directFiling · EDGAR
Dec 22, 2025Shares withheld for tax or exercise price−675$62.72$42K53,162 directFiling · EDGAR
Dec 8, 2025Option or RSU exercised or converted+1,042$39.13$41K51,702 directFiling · EDGAR
Dec 8, 2025Sale under a 10b5-1 plan−1,042$65.96$69K50,660 directFiling · EDGAR

46 earlier transactions are in the filing list below.

All 56 Forms 3, 4, 5 and 144
FiledFormCompanyLinks
Aug 31, 2026Form 4Cytokinetics CYTKFiling · EDGAR
Jul 30, 2026Form 144Cytokinetics CYTKFiling · EDGAR
Jul 30, 2026Form 4Cytokinetics CYTKFiling · EDGAR
Jul 2, 2026Form 4Cytokinetics CYTKFiling · EDGAR
Jun 1, 2026Form 4Cytokinetics CYTKFiling · EDGAR
May 5, 2026Form 4Cytokinetics CYTKFiling · EDGAR
May 4, 2026Form 4Cytokinetics CYTKFiling · EDGAR
Apr 30, 2026Form 4Cytokinetics CYTKFiling · EDGAR
Apr 15, 2026Form 144Cytokinetics CYTKFiling · EDGAR
Apr 15, 2026Form 4Cytokinetics CYTKFiling · EDGAR
Mar 31, 2026Form 144Cytokinetics CYTKFiling · EDGAR
Mar 31, 2026Form 4Cytokinetics CYTKFiling · EDGAR
Mar 18, 2026Form 144Cytokinetics CYTKFiling · EDGAR
Mar 18, 2026Form 4Cytokinetics CYTKFiling · EDGAR
Mar 18, 2026Form 4Cytokinetics CYTKFiling · EDGAR
Mar 17, 2026Form 4Cytokinetics CYTKFiling · EDGAR
Mar 16, 2026Form 144Cytokinetics CYTKFiling · EDGAR
Mar 16, 2026Form 4Cytokinetics CYTKFiling · EDGAR
Mar 10, 2026Form 4Cytokinetics CYTKFiling · EDGAR
Mar 5, 2026Form 4Cytokinetics CYTKFiling · EDGAR
Mar 2, 2026Form 4Cytokinetics CYTKFiling · EDGAR
Feb 5, 2026Form 4Cytokinetics CYTKFiling · EDGAR
Feb 2, 2026Form 4Cytokinetics CYTKFiling · EDGAR
Jan 5, 2026Form 4Cytokinetics CYTKFiling · EDGAR
Jan 2, 2026Form 144Cytokinetics CYTKFiling · EDGAR
Jan 2, 2026Form 4Cytokinetics CYTKFiling · EDGAR
Dec 30, 2025Form 4Cytokinetics CYTKFiling · EDGAR
Dec 29, 2025Form 144Cytokinetics CYTKFiling · EDGAR
Dec 29, 2025Form 4Cytokinetics CYTKFiling · EDGAR
Dec 8, 2025Form 4Cytokinetics CYTKFiling · EDGAR
Dec 5, 2025Form 144Cytokinetics CYTKFiling · EDGAR
Dec 5, 2025Form 4Cytokinetics CYTKFiling · EDGAR
Dec 5, 2025Form 4Cytokinetics CYTKFiling · EDGAR
Jun 5, 2025Form 4Cytokinetics CYTKFiling · EDGAR
May 5, 2025Form 4Cytokinetics CYTKFiling · EDGAR
Apr 7, 2025Form 144Cytokinetics CYTKFiling · EDGAR
Apr 7, 2025Form 4Cytokinetics CYTKFiling · EDGAR
Mar 18, 2025Form 4Cytokinetics CYTKFiling · EDGAR
Mar 17, 2025Form 4Cytokinetics CYTKFiling · EDGAR
Mar 17, 2025Form 4Cytokinetics CYTKFiling · EDGAR
Mar 14, 2025Form 144Cytokinetics CYTKFiling · EDGAR
Mar 14, 2025Form 4Cytokinetics CYTKFiling · EDGAR
Mar 13, 2025Form 144Cytokinetics CYTKFiling · EDGAR
Mar 13, 2025Form 4Cytokinetics CYTKFiling · EDGAR
Mar 7, 2025Form 4Cytokinetics CYTKFiling · EDGAR
Mar 5, 2025Form 4Cytokinetics CYTKFiling · EDGAR
Dec 5, 2024Form 4Cytokinetics CYTKFiling · EDGAR
Mar 18, 2024Form 4Cytokinetics CYTKFiling · EDGAR
Mar 7, 2024Form 4Cytokinetics CYTKFiling · EDGAR
Mar 7, 2023Form 4Cytokinetics CYTKFiling · EDGAR
Mar 3, 2023Form 4Cytokinetics CYTKFiling · EDGAR
Feb 17, 2023Form 4Cytokinetics CYTKFiling · EDGAR
Mar 3, 2022Form 4Cytokinetics CYTKFiling · EDGAR
Feb 17, 2022Form 4Cytokinetics CYTKFiling · EDGAR
Apr 5, 2021Form 4Cytokinetics CYTKFiling · EDGAR
Mar 18, 2021Form 3Cytokinetics CYTKFiling · EDGAR

Every figure is as filed with the SEC on Forms 3, 4, 5 and 144. Holdings are the amounts reported after each person's latest filing at each company and can be out of date. Matching a Form 144 notice to Form 4 sales is SEC Tracker's inference from owner, company, dates and share counts, not something the filings state. Not investment advice. Not affiliated with the U.S. SEC.

Data on this page was fetched . The filing on SEC.gov is the record.